Skip to content

AbbVie ABBV Indefinite-Lived Intangible Assets

Indefinite-Lived Intangible Assets at other companies

Pfizer logo
PfizerPFE
Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$441.54B+33.2%
P/E121.5×+33.4×
P/S+1.3×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's indefinite-lived intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's indefinite-lived intangible assets?
AbbVie (ABBV) reported indefinite-lived intangible assets of $5.27B in Q1 2026.
How has AbbVie's indefinite-lived intangible assets changed year-over-year?
AbbVie's indefinite-lived intangible assets decreased by 0.4% year-over-year, from $5.29B to $5.27B.
What is the long-term trend for AbbVie's indefinite-lived intangible assets?
Over 5 years (2020 to 2025), AbbVie's indefinite-lived intangible assets has grown at a 23.0% compound annual growth rate (CAGR), from $1.88B to $5.28B.
What does indefinite-lived intangible assets mean?
This represents intangible assets, such as iconic brand names or trademarks, that are expected to generate cash flows for an unlimited period. Unlike finite-lived assets, these are not amortized but are tested annually for impairment. They represent the core long-term value of the company's brand portfolio.